Imaging of Inflamed and Vulnerable Plaque in Coronary Arteries with ¹⁸F-FDG PET/CT in Patients with Suppression of Myocardial Uptake Using a Low-Carbohydrate, High-Fat Preparation

10.1046/j.1365-2796.2000.00654.x

10.1161/01.CIR.89.5.2462

10.1161/01.CIR.92.5.1355

10.1161/01.CIR.0000020548.60110.76

10.1016/j.jacc.2006.03.069

10.1016/j.jacc.2006.11.046

10.1016/j.jacc.2007.05.024

10.1111/j.1540-8183.2006.00100.x

10.1161/01.CIR.0000068315.98705.CC

10.1161/CIRCULATIONAHA.106.660340

10.1161/CIRCULATIONAHA.106.647164

10.1016/j.chembiol.2007.10.005

10.1097/01.rli.0000254409.79193.96

2006, J Nucl Med., 47, 273P

Williams G, Kolodny G. Method for detecting biological active coronary artery disease (CAD) by F18-fluorodeoxyglucose (FDG): positron emission tomography (PET)/computed tomography (CT). Paper presented at: Radiological Society of North America; December 2006; Chicago, Illinois.

2003, Biochem Soc Trans., 31, 1115, 10.1042/bst0311115

10.2214/AJR.07.3205

10.2214/AJR.07.2409

10.2214/AJR.06.1058

2004, J Nucl Med., 45, 1794

10.1161/01.CIR.102.5.506

10.1073/pnas.0606281104

10.1136/ard.2003.015701

10.1186/1471-2385-6-3

2006, J Invasive Cardiol., 18, 528

10.1016/j.ejrad.2007.03.028

10.1016/j.jacc.2005.10.067

10.1016/S0002-9149(02)02962-4

10.1097/00001573-200211000-00012

10.1080/14628840410030397

10.1111/j.1540-8183.2006.00099.x

10.1016/j.jacc.2005.10.058

10.1007/s00330-003-1889-5

10.1016/j.atherosclerosis.2004.01.041

10.1161/01.STR.0000190896.67743.b1

10.1007/s00259-005-0005-2